Glaukos Corporation Glaukos Corporation

Glaukos Corporation

GKOS

Peringkat dalam Saham #2027
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Harga Saham
$174.03
Terakhir disinkronkan: 2026-10-20
Kapitalisasi Pasar
$10.26B
Perubahan (1 hari)
4.34%
Perubahan (1 tahun)
129.35%
Negara
US
Perdagangan Glaukos Corporation (GKOS)

Kategori

Healthcare
Riwayat pemecahan saham untuk Glaukos Corporation (GKOS)
Saham Glaukos Corporation (simbol: GKOS) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Oct 21, 2026.
Satu lembar saham GKOS yang dibeli sebelum Oct 21, 2026 sekarang setara dengan 0 lembar saham GKOS.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
9 x285
US
7 x127
IE
9 x162
US
2 x4
US
0 -
DE